Journals / European Journal of Rheumatology / 2020 / Cilt: 7 - Sayı: 4

The importance of Mediterranean fever gene in familialMediterranean fever

Pages
173–176
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no wild type among the patients.Conclusion: In conclusion, the fact that a vast majority of the disease burden was constituted by the exon 10, especially M694V mutations and that none of the 837 patients from our cohort had a wildtype FMF proved the significance of MEFV gene mutation analysis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Familial Mediterranean fever (FMF) is the most common autoinflammatory disease characterized by recurrent serositis attacks and fever.
📊
Key Findings & Data:Our knowledge about the relationship between the MEFV gene and FMF phenotype increases each day.
💡
Conclusion & Impact:There was no wild type among the patients.Conclusion: In conclusion, the fact that a vast majority of the disease burden was constituted by the exon 10, especially M694V mutations and that none of the 837 patients from our cohort had a wildtype FMF proved the significance of MEFV gene mutation analysis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Familial Mediterranean fever (FMF) is the most common autoinflammatory disease characterized by recurrent serositis attacks and fever. The discovery of the Mediterranean fever (MEFV) gene has been a milestone in FMF etiopathogenesis. Our knowledge about the relationship between the MEFV gene and FMF phenotype increases each day. This study aims to investigate the relationship between MEFV gene mutations and the FMF clinical findings of a single-center FMF cohort.Methods: Gender, age, age at symptom onset, age at diagnosis, clinical characteristics, and MEFV gene analysis of the patients were recorded.Results: A total of 837 FMF patients were included in this study. There were 515 females and 322 males. The age at symptom onset was 18.3±10.9 years, while the age at diagnosis was 24.4±10.9 years. The most common symptom that accompanied fever was peritonitis (91.1%), while the other common clinical findings were pleuritis (45%), myalgia (44%), and arthritis (36%). A total of 47 patients developed amyloidosis. A total of 553 (66%) FMF patients had M694V mutation, 221 (26%) of which were homozygous, while 332 (40%) were heterozygous. Exon 10 mutation frequency was 759 (91%), while the non-exon 10 mutation frequency was 78 (9%). There was no wild type among the patients.Conclusion: In conclusion, the fact that a vast majority of the disease burden was constituted by the exon 10, especially M694V mutations and that none of the 837 patients from our cohort had a wildtype FMF proved the significance of MEFV gene mutation analysis. Therefore, we speculate that it is necessary to examine the MEFV gene mutations in each FMF suspected case. It seems plausible to re-evaluate the FMF diagnosis for cases in which a wild type MEFV gene mutation occurs.

🔖

Cite This Article

KEHRİBAR, D. Y., ÖZGEN, M. (2022). The importance of Mediterranean fever gene in familialMediterranean fever. European Journal of Rheumatology, Cilt: 7 - Sayı: 4, 173–176. https://ajindex.com/articles/511560

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Rigante D. The broad-ranging panorama of systemic autoinflammatory disorders with specific focus on acute painful symptoms and hematologic manifestations in children. Mediterr J Hematol Infect Dis 2018
  2. e2018067. [Crossref] 2. Sönmez HE, Batu ED, Özen S. Familial Mediterranean fever: Current perspectives. J Inflamm Res 2016
  3. [Crossref] 3. Sarı İ, Birlik M, Kasifoğlu T. Familial Mediterranean fever: An updated review. Eur J Rheumatol 2014
  4. [Crossref] 4. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967
  5. [Crossref] 5. Manna R, Rigante D. Familial Mediterranean fever: Assessing the overall clinical impact and formulating treatment plans. Mediterr J Hematol Infect Dis 2019
  6. e2019027. [Crossref] 6. Heller H, Karif J, Sherf L, Sohar E. [Familial Mediterranean fever]. Harefuah 1955
  7. Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med 1972
  8. [Crossref] 8. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997
  9. [Crossref] 9. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997
  10. [Crossref] 10. Abderrazak A, Syrovets T, Couchie D, El Hadri K, Friguet B, Simmet T, et al. NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol 2015
  11. [Crossref] 11. Bozkurt Y, Demir A, Erman B, Gül A. Unified modeling of familial Mediterranean fever and cryopyrin associated periodic syndromes. Comput Math Methods Med 2015
  12. 893507.2. [Crossref] 12. Franchi L, Eigenbröd T, Munoz-Planillo R, Nuñez G. The inflammasome
  13. a caspase-1- activation platform that regulates immune response and disease pathogenesis. Nat Immunol 2009
  14. [Crossref] 13. Familial Mediterranean fever, review of the literature. Alghamdi M.Clin Rheumatol 2017
  15. [Crossref] 14. Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil H. Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: A multicentre study. Rheumatology (Oxford) 2014
  16. [Crossref] 15. Van ser Hilst JC, Simon A, Drenth JP. Herediaty periodic fever and reactive amyloidosis. Clin Exp Med 2005
  17. [Crossref] 16. Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup